Abstract:Background: HOIP is the catalytic subunit of the E3 ligase complex (linear ubiquitin chain assembly complex), which is able to generate linear ubiquitin chains. However, the role of rare HOIP functionally deficient variants remains unclear. The pathogenic mechanism and the relationship with immune deficiency phenotypes remain to be clarified. Methods: Based on a next-generation sequencing panel of 270 genes, we identified a HOIP deletion variant that causes common variable immunodeficiency disease. Bioinformatics analysis and cell-based experiments were performed to study the molecular mechanism by which the variant causes immunodeficiency diseases. Findings: A homozygous loss-of-function variant in HOIP was identified. The variant causes a frameshift and generates a premature termination codon in messenger RNA, resulting in a C-terminal truncated HOIP mutant, that is, the loss of the linear ubiquitin chain-specific catalytic domain. The truncated HOIP mutant has impaired E3 ligase function in linear ubiquitination, leading to the suppression of canonical NF-κB signalling and increased TNF-induced multiple forms of cell death. Interpretation: The loss-of-function HOIP variant accounts for the immune deficiencies. The canonical NF-κB pathway and cell death are involved in the pathogenesis of the disease. Funding: This study was funded by the National Natural Science Foundation of China (No. 82270444 and 81501851). Research in context: Evidence before this study LUBAC is the only known linear ubiquitin chain assembly complex for which HOIP is an essential catalytic subunit. Three HOIP variants have now been identified in two immunodeficient patients and functionally characterised. However, there have been no reports on the pathogenicity of only catalytic domain deletion variants in humans, or the pathogenic mechanisms of catalytic domain deletion variants. Added value of this study We report the first case of an autosomal recessive homozygous deletion variant that results in deletion of the HOIP catalytic structural domain. We demonstrate that this variant is a loss-of-function variant using a heterologous expression system. The variant has impaired E3 ligase function. It can still bind to other subunits of LUBAC, but it fails to generate linear ubiquitin chains. We also explored the underlying mechanisms by which this variant leads to immunodeficiency. The variant attenuates the canonical NF-κB and MAPK signalling cascades and increases the sensitivity of TNFα-induced diverse cell death and activation of mitochondrial apoptosis pathways. These findings provide support for the treatment and drug development of patients with inborn errors of immunity in HOIP and related signalling pathways. Implications of all the available evidence First, this study expands the HOIP pathogenic variant database and phenotypic spectrum. Furthermore, studies on the biological functions of pathogenic variants in relation to the NF-κB signalling pathway and cell death provided new understanding into the genetic basis and pathogenesis of HOIP-deficient immune disease, indicating the necessity of HOIP and related signalling pathway variants as diagnostic targets in patients with similar genetic deficiency phenotypes..

A gain-of-function variation in PLCG1 causes a new immune dysregulation disease

Characterization of a Novel Pathogenic PLCG2 Variant Leading to APLAID Syndrome Responsive to a TNF Inhibitor.

A Hypermorphic Missense Mutation in PLCG2, Encoding Phospholipase Cγ2, Causes a Dominantly Inherited Autoinflammatory Disease with Immunodeficiency.

OP0174 Exome Sequencing Identifies a Hypermorphic Missense Mutation in the PLCG2 Gene As the Cause of a Dominantly Inherited Autoinflammatory Disease with Immunodeficiency

Characterisation of molecular mechanisms for PLCγ2 disease-linked variants

PLCG2-associated immune dysregulation (PLAID) comprises broad and distinct clinical presentations related to functional classes of genetic variants

Splice site and de novo mutations can cause mixed dominant negative/gain of function PLCG2-associated immune dysregulation with cold urticaria (CU-PLAID)

Human PLCG2 haploinsufficiency results in a novel natural killer cell immunodeficiency

Loss-of-phosphorylation of IKZF1 results in gain-of-function associated with immune dysregulation

Identification of novel NFKB1 and ICOS frameshift variants in patients with CVID

Dominant-negative NFKBIA mutation promotes IL-1β production causing hepatic disease with severe immunodeficiency

Mutations in PLCG1 Is a Frequent Event in Cutaneous T-Cell Lymphomas

Identification of an IL-1 receptor mutation driving autoinflammation directs IL-1-targeted drug design

Alzheimer's disease phospholipase C-gamma-2 (PLCG2) protective variant is a functional hypermorph

PLCβ2 Negatively Regulates the Inflammatory Response to Virus Infection by Inhibiting Phosphoinositide-Mediated Activation of TAK1.

Clinical Implications of a New DDX58 Pathogenic Variant That Causes Lupus Nephritis Due to RIG-I Hyperactivation

A novel HOIP frameshift variant alleviates NF-kappaB signalling and sensitizes cells to TNF-induced death

Myeloid-specific deletion of group VIA calcium-independent phospholipase A2 induces pro-inflammatory LPS response predominantly in male mice via MIP-1α activation

Loss-of-function Mutations in TNFAIP3 Leading to A20 Haploinsufficiency Cause an Early-Onset Autoinflammatory Disease

Heterozygous Splice Mutation in PIK3R1 Causes Human Immunodeficiency with Lymphoproliferation Due to Dominant Activation of PI3K.

Positional cloning uncovers mutations in PLCE1 responsible for a nephrotic syndrome variant that may be reversible